There are a few things to remember about altmetrics when tapping into non-traditional methods of metrics reporting. Graphic by Miguel Tovar/University of Houston

Alternative metrics, or “altmetrics,” refers to the use of non-traditional methods for judging a researcher’s reach and impact.

Being published in a peer-reviewed journal is surely a great feat. It’s the typical way professors get their research out there. But the tools established to measure this output might end up giving the skewed impression about an author’s impact in spheres both academic and social.

Traditional metrics

Web of Science and Scopus are the main platforms that researchers rely on for collecting article citations. Web of Science’s indexing goes back to 1900, and Scopus boasts the largest database abstract and citations. The caveat with these repositories is that each resource only gives you a rating based on the range and breadth of journals it indexes. Different journals are recorded in different tools, so you may not be getting a comprehensive metric from either.

Let’s talk about h index

The h index is probably never going away, although it is always being improved upon.

An h index is a complex equation that tells the story of how often a researcher is cited. For instance, if a scholar published six papers, and all six papers were each cited by at least six other authors, they would have an h index of 6.

This equation doesn’t work out too well for an academic who, say, had one paper that was continuously cited – they would still have an h index of 1. Brené Brown, Ph.D., even with her veritable empire of vulnerability and shame related self-help has h index of 7 according to Semantic Scholar.

On to altmetrics

When a psychology professor goes on a morning show to discuss self-esteem of young Black women, for instance, she is not helping her h index. Her societal impact is huge, however.

“When I use altmetrics to deliver a professor his or her impact report, I seek out nontraditional sources like social media. For instance, I check how many shares, comments or likes they received for their research. Or maybe their work was reported in the news,” said Andrea Malone, Research Visibility and Impact Coordinator at the University of Houston Libraries.

Altmetrics aim to answer the question of how academia accounts for the numerous other ways scholarly work impacts our society. What about performances done in the humanities, exhibitions, gallery shows or novels published by creative writers?

Alternative metrics are especially important for research done in the humanities and arts but can offer social science and hard science practitioners a better sense of their scope as well. With the constant connections we foster in our lives, the bubble of social media and such, there is a niche for everyone.

The equalizer

For some, Twitter or Facebook is where they like to publish or advertise their data or results.

“When altmetrics are employed, the general public finds out about research, and is able to comment, share and like. They can talk about it on Twitter. The impact of the work is outside of academia,” said Malone. She even checks a database to see if any of the professor’s works have been included in syllabi around the country.

Academia.edu is another social network offering a platform for publishing and searching scholarly content. It has a fee for premium access, whereas Google Scholar is free. Its profile numbers are usually high because it can pick up any public data – even a slide of a PowerPoint.

The Big Idea

At the University of Houston, altmetrics are categorized thusly: articles, books and book chapters, data, posters, slides and videos. While one would think there’s no downside to recording all of the many places academic work ends up, there are a few things to remember about altmetrics:

  1. They lack a standard definition. But this is being worked on currently by the NISO Alternative Assessment Metrics Initiative.
  2. Altmetrics data are not normalized. Tell a story with your metrics, but don’t compare between two unlike sources. Youtube and Twitter will deliver different insights about your research, but they can’t be compared as though they measure the same exact thing.
  3. They are time-dependent. Don’t be discouraged if an older paper doesn’t have much to show as far as altmetrics. The newer the research, the more likely it will have a social media footprint, for example.
  4. They have known tracking issues. Altmetrics work best with items that have a Digital Object Identifier (DOI).

So have an untraditional go of it and enlist help from a librarian or researcher to determine where your research is making the biggest societal impact.

------

This article originally appeared on the University of Houston's The Big Idea. Sarah Hill, the author of this piece, is the communications manager for the UH Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.